Bharti Airtel reported a consolidated net profit of Rs 284 crore in Q1 FY22 as against a net loss of Rs 15,933 crore in Q1 FY21. Total revenues increased by 15.3% YoY to Rs 26,854 in the first quarter. EBITDA improved by 30.3% to Rs 13,189 crore in Q1 FY22 from Rs 10,119 crore in Q1 FY21. EBITDA margin was at 49.1% as on 30 June 2021 as compared with 43.4% as on 30 June 2020.
Tata Steel said that rating agency S&P has upgraded the company’s long-term rating to BB from BB-; outlook remains stable. S&P expects Tata Steel’s debt levels to decline materially over the next two years on the company’s commitment to deleverage, supported by strong operating cash flows.
Dr. Reddy’s Laboratories, along with its subsidiaries announced the re-launch of over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA).
Natco Pharma announced that it has transferred the Lenalidomide Capsules ANDA to Arrow International as per an earlier agreement between the parties.
G R Infraprojects has received Letter of Acceptance (LoA) for ‘Construction of Elevated Structures (Viaduct & stations) from Gottigere to Swagath Road Cross of Bangalore Metro Rail Project, Phase- 2 worth Rs 364.87 crore.
Linde India has signed a business transfer agreement with HPS Gases, Vadodara to acquire its entire packaged gases business along with certain distribution assets for an aggregate cash consideration of Rs 27.5 crore.
Powered by Capital Market – Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
Leave a Comment